Top Markets
Coin of the day
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.

Adagio Therapeutics, Inc.

ADGI
Ранг среди акций #16450
Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily... Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily focused on the discovery, development, and subsequent commercialization of antibody-based therapeutics designed to combat infectious diseases across the United States. Its most advanced product candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical trials. This antibody is being evaluated for both the treatment and prevention of coronavirus disease. Adagio Therapeutics also engages in strategic collaborations. It partners with Adimab, LLC to facilitate the discovery and optimization of novel proprietary antibodies. Furthermore, the company works with the Scripps Research Institute on research initiatives aimed at identifying vaccine candidates that could prevent, diagnose, or treat influenza and beta coronaviruses. Founded in 2020, Adagio Therapeutics maintains its headquarters in Waltham, Massachusetts.
Цена акции
$4.64
Последняя синхронизация: 2022-09-12
Рыночная капитализация
$293.43M
Изменение (1 день)
0.87%
Изменение (1 год)
0.00%
Страна
US
Торговля Adagio Therapeutics, Inc. (ADGI)

Категория

История дроблений акций Adagio Therapeutics, Inc. (ADGI)
Акции Adagio Therapeutics, Inc. (символ: ADGI) прошли через 0 дроблений.
Последнее дробление произошло Sep 02, 2026.
Одна акция ADGI, купленная до Sep 02, 2026, сейчас соответствует 0 акциям ADGI.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH